Similar articles for PMID: 21360131

Year	Number of Results
2001	2
2002	3
2003	2
2004	7
2005	9
2006	11
2007	9
2008	9
2009	9
2010	9
2011	3
2012	5
2013	1
2014	2
2015	3
2016	2
2017	2
2019	5
2020	8
2022	2
2023	2
2024	0

1

Monoclonal antibodies for the treatment of severe asthma.

Clienti S, Morjaria JB, Basile E, Polosa R. Clienti S, et al. Curr Allergy Asthma Rep. 2011 Jun;11(3):253-60. doi: 10.1007/s11882-011-0184-9. Curr Allergy Asthma Rep. 2011. PMID: 21360131 Review.

2

Monoclonal antibodies for chronic refractory asthma and pipeline developments.

Polosa R, Casale T. Polosa R, et al. Drug Discov Today. 2012 Jun;17(11-12):591-9. doi: 10.1016/j.drudis.2012.01.012. Epub 2012 Jan 25. Drug Discov Today. 2012. PMID: 22306350 Review.

3

A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G. D'Amato G, et al. Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. doi: 10.2174/187221307782418900. Recent Pat Inflamm Allergy Drug Discov. 2007. PMID: 19075985 Review.

4

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.

Solèr M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G. Solèr M, et al. Eur Respir J. 2001 Aug;18(2):254-61. doi: 10.1183/09031936.01.00092101. Eur Respir J. 2001. PMID: 11529281 Free article. Clinical Trial.

5

Anti-IgE in allergic asthma and rhinitis: an update.

Morjaria JB, Gnanakumaran G, Babu KS. Morjaria JB, et al. Expert Opin Biol Ther. 2007 Nov;7(11):1739-47. doi: 10.1517/14712598.7.11.1739. Expert Opin Biol Ther. 2007. PMID: 17961096 Review.

6

Disabling inflammatory pathways with biologics and resulting clinical outcomes in severe asthma.

Caruso M, Crisafulli E, Demma S, Holgate S, Polosa R. Caruso M, et al. Expert Opin Biol Ther. 2013 Mar;13(3):393-402. doi: 10.1517/14712598.2013.743989. Epub 2013 Jan 7. Expert Opin Biol Ther. 2013. PMID: 23289846 Review.

7

Anti-IgE antibodies for the treatment of asthma.

Buhl R. Buhl R. Curr Opin Pulm Med. 2005 Jan;11(1):27-34. doi: 10.1097/01.mcp.0000147860.83639.30. Curr Opin Pulm Med. 2005. PMID: 15591885 Review.

8

IgE and eosinophils as therapeutic targets in asthma.

Patel TR, Sur S. Patel TR, et al. Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):42-49. doi: 10.1097/ACI.0000000000000336. Curr Opin Allergy Clin Immunol. 2017. PMID: 27906698 Review.

9

Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update.

D'Amato G, Perticone M, Bucchioni E, Salzillo A, D'Amato M, Liccardi G. D'Amato G, et al. Eur Ann Allergy Clin Immunol. 2010 Aug;42(4):135-40. Eur Ann Allergy Clin Immunol. 2010. PMID: 21114196 Review.

10

What is new in antiimmunoglobulin E asthma therapy.

Berger WE. Berger WE. Allergy Asthma Proc. 2005 Nov-Dec;26(6):428-34. Allergy Asthma Proc. 2005. PMID: 16541964 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year